To date, we’ve completed preclinical studies in several major cancers. An investigator-initiated Phase I trial is underway, and manufacturing process for the Phase II investigational drug is already in place.
To date, we’ve completed preclinical studies in several major cancers. An investigator-initiated Phase I trial is underway, and manufacturing process for the Phase II investigational drug is already in place.